Tian Kang Biology (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao National Pharmaceutical Daichuang...
Zhithong Finance APP News, Tian Kang Biology (688046.SH) announced that on September 24, 2024, the company's shareholder Qingdao National Pharmaceutical Daichuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao National Pharmaceutical") reduced the company's shares by 0.8882 million shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, the shareholder Qingdao National Pharmaceutical's holding of company shares reduced to 5%.